Cited In for PMID: 19329547

Year	Number of Results
2009	3
2010	3
2011	4
2012	6
2013	4
2014	6
2015	3
2016	4
2017	5
2018	3
2019	2
2020	2
2021	4
2022	3
2023	2
2024	0

1

Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse.

Jasinski DR, Krishnan S. Jasinski DR, et al. J Psychopharmacol. 2009 Jun;23(4):419-27. doi: 10.1177/0269881109103113. Epub 2009 Mar 27. J Psychopharmacol. 2009. PMID: 19329547 Clinical Trial.

2

The Use of Lisdexamfetamine to Treat ADHD in a Patient with Stimulant (Methamphetamine) Use Disorder.

Levine J, Swanson H. Levine J, et al. Case Rep Psychiatry. 2023 Aug 14;2023:5574677. doi: 10.1155/2023/5574677. eCollection 2023. Case Rep Psychiatry. 2023. PMID: 37609571 Free PMC article.

3

Development of Child-Friendly Lisdexamfetamine Chewable Tablets Using Ion Exchange Resin as a Taste-Masking Carrier Based on the Concept of Quality by Design (QbD).

Zhu C, Chen J, Shi L, Liu Q, Liu C, Zhang F, Wu H. Zhu C, et al. AAPS PharmSciTech. 2023 Jun 8;24(5):132. doi: 10.1208/s12249-023-02592-x. AAPS PharmSciTech. 2023. PMID: 37291437

4

Neuroprotection in late life attention-deficit/hyperactivity disorder: A review of pharmacotherapy and phenotype across the lifespan.

Dutta CN, Christov-Moore L, Ombao H, Douglas PK. Dutta CN, et al. Front Hum Neurosci. 2022 Sep 26;16:938501. doi: 10.3389/fnhum.2022.938501. eCollection 2022. Front Hum Neurosci. 2022. PMID: 36226261 Free PMC article. Review.

5

Abuse Potential of Cathinones in Humans: A Systematic Review.

Poyatos L, Torres A, Papaseit E, Pérez-Mañá C, Hladun O, Núñez-Montero M, de la Rosa G, Torrens M, Fuster D, Muga R, Farré M. Poyatos L, et al. J Clin Med. 2022 Feb 15;11(4):1004. doi: 10.3390/jcm11041004. J Clin Med. 2022. PMID: 35207278 Free PMC article. Review.

6

Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology.

Heal DJ, Smith SL. Heal DJ, et al. J Psychopharmacol. 2022 Jun;36(6):680-703. doi: 10.1177/02698811211032475. Epub 2021 Jul 28. J Psychopharmacol. 2022. PMID: 34318734 Free PMC article. Review.

7

Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study.

Ezard N, Clifford B, Dunlop A, Bruno R, Carr A, Liu Z, Siefried KJ, Lintzeris N. Ezard N, et al. BMJ Open. 2021 May 18;11(5):e044696. doi: 10.1136/bmjopen-2020-044696. BMJ Open. 2021. PMID: 34006547 Free PMC article. Clinical Trial.

8

Converging vulnerability factors for compulsive food and drug use.

Serafine KM, O'Dell LE, Zorrilla EP. Serafine KM, et al. Neuropharmacology. 2021 Sep 15;196:108556. doi: 10.1016/j.neuropharm.2021.108556. Epub 2021 Apr 20. Neuropharmacology. 2021. PMID: 33862029 Free PMC article. Review.

9

Open-label pilot study of lisdexamfetamine for cocaine use disorder.

Mariani JJ, Choi CJ, Pavlicova M, Mahony AL, Brooks DJ, Grabowski J, Levin FR. Mariani JJ, et al. Am J Drug Alcohol Abuse. 2021 May 4;47(3):402-409. doi: 10.1080/00952990.2021.1885677. Epub 2021 Apr 2. Am J Drug Alcohol Abuse. 2021. PMID: 33797985 Free PMC article. Clinical Trial.

10

Long-term study of lisdexamfetamine dimesylate in Japanese children and adolescents with attention-deficit/hyperactivity disorder.

Ichikawa H, Miyajima T, Yamashita Y, Fujiwara M, Fukushi A, Saito K. Ichikawa H, et al. Neuropsychopharmacol Rep. 2020 Mar;40(1):52-62. doi: 10.1002/npr2.12091. Epub 2019 Dec 8. Neuropsychopharmacol Rep. 2020. PMID: 31814294 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

50 results

Results by year